Enoxaparin Sodium Injection
Product Images NDC 71288-437

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 71288-437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 100 mg Blister Pack Label (Enox 100mg Ht Blister V2)

Label for Enoxaparin Sodium Injection, USP 100 mg per mL by Meitheal Pharmaceuticals Inc. The label specifies the drug is for subcutaneous use and includes dosing and safety instructions. It includes the NDC number 71288-436-91 and spaces for lot and expiration dates.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 100 mg Carton (Enox 100mg Ht Carton V2)

Packaging label for Enoxaparin Sodium Injection, USP 100 mg per mL by Meitheal Pharmaceuticals Inc. The label indicates 10 x 1 mL single-dose prefilled syringes with automatic safety device for subcutaneous use. It includes storage instructions, warnings, and manufacturer details.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 120 mg Blister Pack Label (Enox 120mg Ht Blister V2)

Label for Enoxaparin Sodium Injection USP, 120 mg per 0.8 mL, subcutaneous injection. The label includes dosage instructions, warnings, storage information, NDC number 71288-437-93, barcode, and is branded by Meitheal Pharmaceuticals Inc. The label features a purple and brown color scheme with white text detailing usage and safety.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 120 mg Carton (Enox 120mg Ht Carton V2)

Packaging label for Enoxaparin Sodium 120 mg per 0.8 mL injection, USP, manufactured by Meitheal Pharmaceuticals Inc. The label indicates a single-dose prefilled syringe with an automatic safety device for subcutaneous use. The package contains 10 syringes of 0.8 mL each. Storage instructions and product warnings are included, along with a barcode and manufacturer information.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 150 mg Blister Pack Label (Enox 150mg Ht Blister V2)

Box label for Enoxaparin Sodium Injection, USP 150 mg per mL by Meitheal Pharmaceuticals Inc. The label includes usage instructions for subcutaneous injection, dosage and administration details, NDC 71288-438-95, and caution notes. The text PEEL HERE appears on the left edge.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 150 mg Carton (Enox 150mg Ht Carton V2)

Packaging label for Enoxaparin Sodium 150 mg/mL injection by Meitheal Pharmaceuticals Inc. The label indicates a 10 x 1 mL single-dose prefilled syringe carton with an automatic safety device for subcutaneous use. The design features blue and black colors with dosage, usage instructions, and safety warnings prominently displayed.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 30 mg Blister Pack Label (Enox 30mg Ht Blister V2)

Label for Enoxaparin Sodium Injection, USP 30 mg per 0.3 mL, manufactured by Meitheal Pharmaceuticals Inc. The label indicates subcutaneous use and use with an automatic safety device syringe. The label includes warnings, lot and expiration date fields, and a barcode.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 30 mg Carton (Enox 30mg Ht Carton V2)

Packaging label for Enoxaparin Sodium Injection, USP, 30 mg per 0.3 mL, presented in 10 single-dose prefilled syringes with automatic safety devices. The label indicates the product is for subcutaneous use and is manufactured by Meitheal Pharmaceuticals Inc. The design includes dosing and warning information, storage conditions, and barcode details.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 40 mg Blister Pack Label (Enox 40mg Ht Blister V2)

Label for Enoxaparin Sodium Injection, USP, showing 40 mg per 0.4 mL strength. The label includes the NDC number 71288-433-91, states Rx only, and specifies subcutaneous use with a 0.4 mL dose. It is labeled for use with an automatic safety device syringe and is distributed by Meitheal Pharmaceuticals Inc. A barcode and space for lot and expiry dates are present.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 40 mg Carton (Enox 40mg Ht Carton V2)

Packaging label for Enoxaparin Sodium 40 mg per 0.4 mL injection, USP. The product is a subcutaneous injection presented in 10 single-dose prefilled syringes with an automatic safety device. The labeler is Meitheal Pharmaceuticals Inc. The label includes storage instructions, warnings, and dosage form details.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 60 mg Blister Pack Label (Enox 60mg Ht Blister V2)

Label for Enoxaparin Sodium Injection, USP, 60 mg per 0.6 mL dosage strength. This subcutaneous injection is manufactured by Meitheal Pharmaceuticals Inc. The label includes dosage instructions for use with the dosing device, warnings, storage information, and a barcode. The product is designated Rx Only with NDC 71288-434-91.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 60 mg Carton (Enox 60mg Ht Carton V2)

Packaging label for Enoxaparin Sodium Injection, USP, 60 mg per 0.6 mL, in single-dose prefilled syringes. The label indicates subcutaneous use and includes the NDC 71288-434-92. Manufactured by Meitheal Pharmaceuticals Inc., the box contains 10 syringes with an automatic safety device. The labeling highlights sterility, preservative-free status, and storage instructions at controlled room temperature.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 80 mg Blister Pack Label (Enox 80mg Ht Blister V2)

Label for Enoxaparin Sodium Injection, USP, 80 mg per 0.8 mL in a subcutaneous injection dosage form. The label includes the NDC number 71288-435-91 and states it is for Rx only. The label also includes usage instructions and a barcode. The labeler is Meitheal Pharmaceuticals Inc.*

FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 80 mg Carton (Enox 80mg Ht Carton V2)

Packaging label for Enoxaparin Sodium 80 mg per 0.8 mL injection, USP, by Meitheal Pharmaceuticals Inc. The product is supplied as 10 single-dose prefilled syringes with an automatic safety device for subcutaneous use. The label includes storage instructions, warnings, and manufacturer details.*

FDA Label Image

Figure A (Enox Ifu A)

An instructional illustration showing a Sharps Disposal Container alongside a prefilled syringe labeled Enoxaparin Sodium Injection. The image also includes an alcohol wipe, a small adhesive bandage, and a cotton ball or gauze, depicting items typically used when administering a subcutaneous injection.*

FDA Label Image

Figure B (Enox Ifu B)

An instructional illustration showing hands removing or placing a protective cap on a syringe prefilled with Enoxaparin Sodium injection for subcutaneous use. The image demonstrates safe handling and preparation of the injection device.*

FDA Label Image

Figure C (Enox Ifu C)

An instructional illustration of a prefilled syringe of Enoxaparin Sodium injection. The syringe includes a cap on one end, a barrel with a visible plunger mechanism, and an expiration date label area. It is designed for subcutaneous administration.*

FDA Label Image

Figure D (Enox Ifu D)

A black and white line drawing of a prefilled syringe labeled with "Clear Liquid" indicating the content inside. The syringe has a plunger with a textured grip and a needle end, designed for injection use. No additional product labeling or dosage information is shown in the image.*

FDA Label Image

Figure E (Enox Ifu E)

An illustration showing the abdomen area of a person's body, likely demonstrating the site for subcutaneous injection on the lower abdomen. The image highlights both sides of the stomach with shaded rectangular areas, possibly indicating recommended injection sites.*

FDA Label Image

Figure F (Enox Ifu F)

An instructional diagram showing a person with a hand positioned near the abdomen, demonstrating the typical area for subcutaneous injection of Enoxaparin Sodium injection. The illustration highlights the injection site on the lower abdominal area.*

FDA Label Image

Figure G (Enox Ifu G)

An instructional illustration showing hands preparing a syringe for injection. One hand is holding a syringe while the other hand is removing a protective cap from the needle. Arrows indicate the direction of cap removal, demonstrating how to ready the syringe prior to administration.*

FDA Label Image

Figure H (Enox Ifu H)

An instructional diagram showing a gloved hand holding a syringe for injection. The syringe has a plunger being pressed down, indicated by a downward arrow, with the text 'Set your dose' nearby. This image demonstrates proper syringe dose setting technique.*

FDA Label Image

Figure I (Enox Ifu I)

An instructional illustration showing a person injecting subcutaneously into the abdomen, demonstrating proper technique for administering a subcutaneous injection of Enoxaparin Sodium injection.*

FDA Label Image

Figure J (Enox Ifu J)

Illustration showing a person injecting Enoxaparin Sodium injection subcutaneously into the abdominal area. The image depicts proper injection technique with the syringe held at a 90-degree angle to the skin.*

FDA Label Image

Figure K (Enox Ifu K)

An instructional illustration showing a person performing a subcutaneous injection into the abdomen area. The image depicts the hand holding a syringe with a needle inserted just under the skin, indicating proper injection technique for Enoxaparin Sodium injection.*

FDA Label Image

Figure L (Enox Ifu L)

An instructional illustration showing a person administering a subcutaneous injection into the abdominal area using a syringe. The image emphasizes the proper site for injection on the lower abdomen near the navel.*

FDA Label Image

Figure M (Enox Ifu M)

An instructional illustration showing a hand holding an Enoxaparin Sodium prefilled injection syringe. The image highlights the protective sleeve on the syringe and indicates a "CLICK" sound, demonstrating how to properly prepare or use the syringe for subcutaneous injection.*

FDA Label Image

Figure N (Enox Ifu N)

An instructional illustration showing a hand disposing of an Enoxaparin Sodium injection syringe into a labeled sharps disposal container. The syringe and needle cap are clearly indicated, demonstrating safe disposal practices for subcutaneous injection needles.*

FDA Label Image

Syringe Parts (Enox Ifu Parts)

An instructional illustration showing a syringe before and after use. The diagram labels key parts: plunger rod, needle, needle cap, and protective sleeve. It demonstrates the transition from a capped needle to a needle covered with a protective sleeve after use.*

FDA Label Image

Figure 1 (Enox Pi Fig 1)

A forest plot chart comparing relative risk percentages of UFH and Enoxaparin Sodium across various patient subgroups. The chart lists subgroups like sex, age, infarct location, diabetes status, prior MI status, fibrinolytic agent type, time to treatment, and PCI in 30 days, showing the number of patients and risk reduction percentages. The horizontal axis indicates relative risk, with bars and markers representing subgroup risk comparisons, suggesting Enoxaparin is generally better.*

FDA Label Image

Figure 2 (Enox Pi Fig 2)

A Kaplan-Meier survival curve chart showing the hazard distribution function for death or myocardial re-infarction over 30 days comparing Enoxaparin and UFH (unfractionated heparin). The chart includes a smaller inset graph extending to 1 year, both with statistically significant log-rank test p-values. The number at risk over time is listed for Enoxaparin and UFH groups below the main graph.*

FDA Label Image

Figure A (Enox Pi Fig A)

An instructional illustration showing two hands holding a syringe and removing the needle cap by pulling it straight off. The image uses arrows pointing outward to indicate the direction for removing the cap from the syringe tip.*

FDA Label Image

Figure B (Enox Pi Fig B)

An instructional black-and-white line drawing showing the use of a syringe for subcutaneous injection. The illustration depicts one hand holding the injection site skin while the other hand inserts the syringe needle at a shallow angle, with an arrow indicating the direction of insertion.*

FDA Label Image

Figure C (Enox Pi Fig C)

An instructional line drawing illustrating a hand holding a syringe with needle pointing toward skin, depicting an injection technique. An arrow indicates the direction of needle insertion for subcutaneous administration.*

FDA Label Image

Figure D (Enox Pi Fig D)

An instructional illustration showing a hand holding a syringe, with an arrow indicating a twisting or removal motion on the syringe cap or protective cover.*

FDA Label Image

Figure E (Enox Pi Fig E)

An instructional illustration showing a gloved hand disposing of a used syringe into a container labeled 'BIOHAZARD.' An arrow points downward, indicating the proper action for safe disposal of injection equipment.*

FDA Label Image

Structural Formula 1 (Enox Structure 1)

Chemical structure diagram of Enoxaparin Sodium, showing repeating disaccharide units with specified groups R1 (H or SO3Na) and R2 (SO3Na or COCH3) as part of the molecular structure representation.*

FDA Label Image

Structural Formula 2 (Enox Structure 2)

Chemical structure of Enoxaparin Sodium showing two sugar rings with associated functional groups including carboxyl, hydroxyl, and sulfate moieties, depicting part of the molecular framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.